Hippocratic AI has announced a strategic partnership with Israel’s Sheba Medical Center to deploy its generative AI agents in clinical and research settings. The collaboration centers on integrating Hippocratic AI’s non-diagnostic, patient-facing agents—initially in triage and patient intake—within Sheba’s ARC Innovation Center, a global hub connecting leading hospitals, researchers, and innovation groups. Through this partnership, Hippocratic AI becomes part of the ARC ecosystem, which brings together clinicians, researchers, and entrepreneurs to drive forward healthcare innovation. CEO Munjal Shah highlighted Sheba’s clinical excellence and collaborative infrastructure as ideal for advancing Hippocratic AI’s mission to scale safe and effective generative AI in healthcare.
This collaboration builds on Hippocratic AI’s broader strategy of global partnerships to address healthcare workforce shortages and enhance patient engagement. Recent partnerships include KPMG, aimed at deploying AI agents to ease provider workloads, and EUCALIA, which brought Hippocratic AI’s capabilities to Japan through the launch of a Japanese-language healthcare agent. The agents are designed to carry out tasks such as appointment scheduling, follow-up communications, and medication adherence. Additionally, Hippocratic AI partnered with Burjeel Holdings in the UAE and Oman to roll out AI tools across clinical facilities, further demonstrating its global momentum in providing personalized, empathetic, and efficient patient care through generative AI.